EVANGELISTI, CECILIA
 Distribuzione geografica
Continente #
NA - Nord America 2.722
AS - Asia 2.125
EU - Europa 1.681
Continente sconosciuto - Info sul continente non disponibili 134
AF - Africa 121
SA - Sud America 114
OC - Oceania 1
Totale 6.898
Nazione #
US - Stati Uniti d'America 2.666
VN - Vietnam 657
SG - Singapore 550
CN - Cina 479
IT - Italia 387
GB - Regno Unito 342
SE - Svezia 249
DE - Germania 203
HK - Hong Kong 128
IN - India 92
FR - Francia 82
RU - Federazione Russa 78
BR - Brasile 72
IE - Irlanda 61
ZA - Sudafrica 45
FI - Finlandia 43
NL - Olanda 38
CH - Svizzera 34
UA - Ucraina 33
KR - Corea 31
BD - Bangladesh 30
TG - Togo 30
EE - Estonia 29
JP - Giappone 29
CI - Costa d'Avorio 28
JO - Giordania 26
CA - Canada 24
BG - Bulgaria 21
BE - Belgio 20
AR - Argentina 18
ID - Indonesia 16
PL - Polonia 16
TH - Thailandia 13
CO - Colombia 11
IR - Iran 10
MX - Messico 10
TR - Turchia 10
PH - Filippine 8
SA - Arabia Saudita 8
AT - Austria 7
ES - Italia 7
IQ - Iraq 7
PK - Pakistan 7
SC - Seychelles 6
CZ - Repubblica Ceca 5
EC - Ecuador 5
JM - Giamaica 5
UZ - Uzbekistan 5
HR - Croazia 4
KZ - Kazakistan 4
PT - Portogallo 4
CR - Costa Rica 3
DZ - Algeria 3
LT - Lituania 3
MA - Marocco 3
MY - Malesia 3
PE - Perù 3
TW - Taiwan 3
CL - Cile 2
DK - Danimarca 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
LB - Libano 2
PR - Porto Rico 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BM - Bermuda 1
BO - Bolivia 1
BZ - Belize 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GP - Guadalupe 1
HT - Haiti 1
IL - Israele 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
SN - Senegal 1
SV - El Salvador 1
VE - Venezuela 1
Totale 6.765
Città #
Singapore 390
Southend 291
Ashburn 275
Fairfield 216
Chandler 194
Houston 166
San Jose 148
Bologna 144
Woodbridge 126
Hong Kong 117
Ho Chi Minh City 115
Dong Ket 110
Seattle 106
Santa Clara 102
Hanoi 100
Wilmington 95
Ann Arbor 91
Cambridge 91
Princeton 64
Beijing 63
Dublin 61
Hefei 54
Council Bluffs 52
Dallas 52
New York 52
Boardman 48
Helsinki 40
Los Angeles 35
Bern 32
Lauterbourg 30
Lomé 30
Westminster 30
Nanjing 29
Abidjan 28
Padova 27
Amman 26
Haiphong 25
Seoul 25
Berlin 23
Milan 22
Redmond 22
Bremen 21
Sofia 21
Frankfurt am Main 20
Turin 20
Brussels 19
Da Nang 19
Tokyo 18
Rome 16
Buffalo 15
Falls Church 15
Johannesburg 15
Shenyang 15
Nuremberg 14
Saint Petersburg 14
Changsha 13
Jinan 13
Redondo Beach 13
Shanghai 13
Chicago 12
The Dalles 12
Warsaw 12
Guangzhou 11
Atlanta 10
Jakarta 9
London 9
São Paulo 9
Tianjin 9
Florence 8
Toronto 8
Bengaluru 7
Dearborn 7
Munich 7
Nanchang 7
Orem 7
Hebei 6
Hải Dương 6
Mexico City 6
Norwalk 6
Pune 6
San Diego 6
Vienna 6
Zhengzhou 6
Bangkok 5
Can Tho 5
Charlotte 5
Denver 5
Falkenstein 5
Hyderabad 5
Jacksonville 5
Jiaxing 5
Medford 5
Mumbai 5
San Francisco 5
Washington 5
Yubileyny 5
Amsterdam 4
Ankara 4
Biên Hòa 4
Chennai 4
Totale 4.314
Nome #
Mutant MYO1F alters the mitochondrial network and induces tumor proliferation in thyroid cancer 283
INPP4B overexpression and c-KIT downregulation in human achalasia. 270
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. 264
CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1 262
Apolipoprotein B is a new target of the GDNF/RET and ET-3/EDNRB signalling pathways 260
Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells. 243
Therapeutic targeting of CK2 in acute and chronic leukemias. 227
Effectiveness and Impact of Transcript Analysis in Clinical Genetics Daily Practice 221
Improving nelarabine efficacy in T-cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. 221
The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells. 218
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 217
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 216
Case report: Functional characterization of a novel CHD7 intronic variant in patients with CHARGE syndrome 209
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications. 207
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 200
Assessment of the effect of sphingosine kinase inhibitors on apoptosis, unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics. 197
C620R mutation of the murine ret proto-oncogene: loss of function effect in homozygotes and possible gain of function effect in heterozygotes. 185
A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors 184
Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia 184
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 184
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies. 183
Targeting Wnt/beta-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia. 180
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the pro-apoptotic NF-κB. 178
Lamin A acts a tumor suppressor in Ewing sarcoma promoting neural differentiation and reducing cell migration and invasion 176
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia. 173
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 173
Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia. 170
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 169
A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer. 167
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia 164
Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation. 148
Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas. 144
Experimental Cell Models for Investigating Neurodegenerative Diseases 140
INHIBITION OF PROLIFERATION AND SURVIVAL IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) CELLS REQUIRES BLOCKADE OF ALL THE CLASS I PI3Ks ISOFORMS 107
Targeting the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in acute myelogenous leukaemia. 92
Low-Level Mosaicism in Tuberous Sclerosis Complex (TSC): Diagnostic and Clinical Implications From Two Novel Cases and Literature Review 80
Induction of regulatory T Cells by dendritic cells through indoleamine 2,3-dioxygenase: a potent mechanism of acquired peripheral tolerance 2
Totale 6.898
Categoria #
all - tutte 18.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.210


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022686 0 0 43 56 75 48 11 44 23 112 155 119
2022/2023799 78 117 38 112 38 70 29 40 149 13 60 55
2023/2024271 26 30 16 30 25 81 8 12 8 8 16 11
2024/2025789 25 94 69 83 143 50 45 37 7 52 45 139
2025/20262.141 159 147 166 152 218 131 264 80 485 165 66 108
2026/2027216 60 67 89 0 0 0 0 0 0 0 0 0
Totale 6.898